Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Dynamic Pharmaceuticals Powershares (PJP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fund basics

See More

Price Performance

See More
Period Period Low Period High Performance
1-Month
60.77 +6.65%
on 08/23/17
66.40 -2.39%
on 09/12/17
+3.65 (+5.97%)
since 08/22/17
3-Month
59.74 +8.49%
on 08/18/17
66.40 -2.39%
on 09/12/17
+1.29 (+2.03%)
since 06/22/17
52-Week
53.55 +21.03%
on 11/04/16
66.40 -2.39%
on 09/12/17
+0.32 (+0.50%)
since 09/22/16

Most Recent Stories

More News
Q2 Earnings Fail to Impress Pharma ETF

The string of earnings beat failed to boost pharma ETFs.

XPH : 42.37 (+0.02%)
JNJ : 131.39 (-0.27%)
MRK : 65.13 (-0.72%)
IHE : 155.80 (-0.22%)
PJP : 64.81 (-0.22%)
LLY : 83.91 (+0.70%)
PFE : 35.96 (-0.03%)
BMY : 63.36 (+0.05%)
Q2 Earnings Fail to Impress Pharma ETF

The string of earnings beat failed to boost pharma ETFs.

XPH : 42.37 (+0.02%)
JNJ : 131.39 (-0.27%)
MRK : 65.13 (-0.72%)
IHE : 155.80 (-0.22%)
PJP : 64.81 (-0.22%)
LLY : 83.91 (+0.70%)
PFE : 35.96 (-0.03%)
BMY : 63.36 (+0.05%)
What Lies Ahead for Pharma ETFs in Second Half 2017

We discuss some of the factors that could contribute to a sustained recovery in the sector.

XPH : 42.37 (+0.02%)
PJP : 64.81 (-0.22%)
IHE : 155.80 (-0.22%)
PPH : 57.73 (+0.42%)
What Lies Ahead for Pharma ETFs in Second Half 2017

We discuss some of the factors that could contribute to a sustained recovery in the sector.

XPH : 42.37 (+0.02%)
PJP : 64.81 (-0.22%)
IHE : 155.80 (-0.22%)
PPH : 57.73 (+0.42%)
Gilead Sciences Posts Mixed Q1 Results: ETFs in Focus

Gilead beat Zacks EPS estimates, but missed on revenue, in the first quarter of 2017.

PJP : 64.81 (-0.22%)
IBB : 329.94 (-0.40%)
BBH : 133.57 (-0.04%)
GILD : 83.27 (+0.79%)
Gilead Sciences Posts Mixed Q1 Results: ETFs in Focus

Gilead beat Zacks EPS estimates, but missed on revenue, in the first quarter of 2017.

PJP : 64.81 (-0.22%)
IBB : 329.94 (-0.40%)
BBH : 133.57 (-0.04%)
GILD : 83.27 (+0.79%)
Trumpcare Collapse Fuels Rally in Healthcare Stocks & ETFs

With the failure of Trumpcare, the healthcare sector looks more stable.

UHS : 109.29 (+0.79%)
BBC : 28.20 (-1.74%)
AC : 34.85 (+1.01%)
XLV : 81.58 (unch)
IHE : 155.80 (-0.22%)
MOH : 65.32 (+4.50%)
LPNT : 57.20 (+1.96%)
THC : 16.32 (+2.51%)
BBP : 40.53 (-0.59%)
XPH : 42.37 (+0.02%)
PBE : 49.10 (-0.65%)
SBIO : 30.74 (-1.54%)
PJP : 64.81 (-0.22%)
CNC : 92.22 (+1.63%)
SPY : 249.44 (+0.02%)
XBI : 83.91 (-0.80%)
Trumpcare Collapse Fuels Rally in Healthcare Stocks & ETFs

With the failure of Trumpcare, the healthcare sector looks more stable.

UHS : 109.29 (+0.79%)
BBC : 28.20 (-1.74%)
AC : 34.85 (+1.01%)
XLV : 81.58 (unch)
IHE : 155.80 (-0.22%)
MOH : 65.32 (+4.50%)
LPNT : 57.20 (+1.96%)
THC : 16.32 (+2.51%)
BBP : 40.53 (-0.59%)
XPH : 42.37 (+0.02%)
PBE : 49.10 (-0.65%)
SBIO : 30.74 (-1.54%)
PJP : 64.81 (-0.22%)
CNC : 92.22 (+1.63%)
SPY : 249.44 (+0.02%)
XBI : 83.91 (-0.80%)
Trump, Biogen and Amgen Hammer Healthcare ETFs

After making a strong comeback in February, the U.S. healthcare sector again witnessed some pain in the last couple of sessions.

CELG : 143.89 (+0.08%)
XLV : 81.58 (unch)
VHT : 152.21 (+0.01%)
MDCO : 35.44 (+1.40%)
IBB : 329.94 (-0.40%)
PFE : 35.96 (-0.03%)
ESPR : 49.31 (-0.12%)
BBP : 40.53 (-0.59%)
XPH : 42.37 (+0.02%)
ABT : 52.51 (+2.10%)
TMO : 188.30 (+0.21%)
PJP : 64.81 (-0.22%)
IYH : 171.97 (+0.05%)
AMG : 184.97 (+0.43%)
BIIB : 318.46 (+1.09%)
Trump, Biogen and Amgen Hammer Healthcare ETFs

After making a strong comeback in February, the U.S. healthcare sector again witnessed some pain in the last couple of sessions.

CELG : 143.89 (+0.08%)
XLV : 81.58 (unch)
VHT : 152.21 (+0.01%)
MDCO : 35.44 (+1.40%)
IBB : 329.94 (-0.40%)
PFE : 35.96 (-0.03%)
ESPR : 49.31 (-0.12%)
BBP : 40.53 (-0.59%)
XPH : 42.37 (+0.02%)
ABT : 52.51 (+2.10%)
TMO : 188.30 (+0.21%)
PJP : 64.81 (-0.22%)
IYH : 171.97 (+0.05%)
AMG : 184.97 (+0.43%)
BIIB : 318.46 (+1.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More

Fund Summary

The PowerShares Dynamic Pharmaceuticals Portfolio is based on the Dynamic Pharmaceutical Intellidex Index. The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating...

See More

Support & Resistance

2nd Resistance Point 65.16
1st Resistance Point 64.99
Last Price 64.81
1st Support Level 64.56
2nd Support Level 64.30

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.